중국의 유전체 기반 의약품 시장

China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population and Labor
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

• Genome-Based Drug Industry Structure
• Market Size
• Market Growth Drivers
• Major Producer Facility Locations and Output
• Market Share of Key Producers
• Labor Costs
• Potential Entrants
• Major Foreign Investments
• Technology Development

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

• Overview
• Genome-Based Drug Sales Volumes and Forecasts (Yuan)
• Cytokines Drug
• Peptide Hormones Drug
• Thrombolytic Agents
• Enzyme Drug
• Soluble Recepter
• Adhesion Molecule
• Nucleic Acid Drug
• Other Genome-Based Drug
• Genome-Based Drug Imports and Exports
• Pricing Trends

V. GENOME-BASED DRUG MARKET OUTLOOKS

• Genome-Based Drug Markets Outlook Overview
• Government Regulations
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Genome-Based Drug Sales by Region
• East
• North
• Central
• South
• West

VI. MARKETING STRATEGIES

• Distribution System in China
• China's Distribution System
• Genome-Based Drug Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China's Market Entry
• Licensing
• Franchising
• E-commerce
• Trading Companies and Local Agents
• Representative Offices and Chinese Subsidiaries
• Wholly Foreign Owned Enterprises

VII. GENOME-BASED DRUG PRODUCER DIRECTORY

• Genome-Based Drug Producer Profiles
• Distributors and Trading Companies
• Research Institutions and Associations